Crowdfunding
The crowdfunding platform CrowdFundMe places an I-RFK charity bond
The proceeds of the i-RFK charity bond will finance the purchase of new stakes in companies operating in expanding markets: healthcare tech, cybersecurity, teleaudiology, gaming, Artificial Intelligence. This is the second bond issued by i-RFK, following the 2020 bond. The bond was listed as planned on ExtraMotPro3, after having been placed in July 2020 on the Italian crowdinvesting portal CrowdFundMe.
Innovative-RFK (i-RFK), an industrial holding company listed on Euronext in Paris that invests in innovative startups and SMEs, is placing a charity bond on the crowdfunding portal listed on Borsa Italiana CrowdFundMe, with a maximum target of $6 million (€5 million).
The minibond has a duration of 60 months, a minimum subscription size of $12,200 (€10,000), and an annual yield of 4% with an amortized repayment plan through a semi-annual coupon in arrears. Moreover, thanks to the collaboration with Lions Club International, the issuer will devolve a part of the resources (2% per year) to charitable activities. The minibond can also be subscribed by retail customers with assets of over $305,000 (€250,000). To date, it has been subscribed for $24,400 (€20,000).
The rating of i-RFK, established by Modefinance (an ESMA-compliant Italian fintech controlled by TeamSystem) is B1 (medium-high), as the holding company presents “an adequate economic-financial situation” and “confirms an extremely solid solvency with strong capitalization (equal to 87% of total sources).”
Read more on the subject and find other important business headlines with the Born2Invest mobile app.
What will the i-RFK charity bond be used for
The proceeds of the i-RFK charity bond will finance the purchase of new stakes in companies operating in expanding markets: healthcare tech, cybersecurity, teleaudiology, gaming, Artificial Intelligence. Regarding the donation to the Lions Club, Marco Stracquadaini, president of the Lions Club Milano Cinque Giornate, said: “The donation will be used to support the many social, cultural and charitable projects of Lions, for the benefit of our community, which is so affected at this particularly difficult time. This is a wonderful opportunity to serve together, especially on the 70th anniversary of the Association’s founding in Italy.
This is the second bond issued by i-RFK, following the 2020 bond. The bond was listed as planned on ExtraMotPro3, after having been placed in July 2020 on the Italian crowdinvesting portal CrowdFundMe. i-RFK successfully closed the placement, raising $1.58 million (€1.29 million) out of a maximum target of $6 million (€5 million), from institutional investors but involving for the first time also retail investors who meet the requirements of the law (with assets over $305,000 (€250,000)). The institutional investors in the minibond also include Banca Valsabbina. In total, the subscribers of this first mixed retail-institutional operation numbered 35.
Innovative-RFK was founded in 2017
i-RFK was founded in 2017 by Paolo Pescetto, Massimo Laccisaglia and Andrea Rossotti. It listed on Euronext Access on December 27th, 2019, following a raise from an equity crowdfunding campaign on CrowdFundMe, which raised $3 million (€2.5 million), or 23.5% of the capital. i-RFK, which has more than 260 employees, an aggregate production value of about $33 million (€27 million), and a market capitalization of $13.4 million (€11 million), comes from the experience of Red-Fish Kapital, which has been operating for several years in the field of private equity investments, also in the form of club deal, alongside private and institutional investors and the consulting firm Arkios Italy.
To date, the group has invested $10.5 million (€8.6 million) in 7 subsidiaries (including Keisdata; Easy4Cloud; Websolute; Inventis; Microcredito di Impresa, which have an aggregate EBITDA of $4.2 million (€3.4 million). Microcredito di Impresa has raised over $2 million (€1.7 million) in its equity crowdfunding campaign on the BacktoWork platform. i-RFK is a growing company. This is confirmed by the aggregate results: the value of production increased to over $32 million (€26 million) in 2019, compared to $29 million (€23.7 million) in 2018 and $20 million (€16.3 million) in 2017.
__
(Featured image by Tech Daily via Unsplash)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Crowdfunding buzz, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Markets2 weeks ago
Markets Surge on Trump Victory—But Can Overvaluation and Recession Risks Stall the Rally?
-
Biotech3 days ago
Sanofi Injects 40 Million Euros to Strengthen Its Production in France
-
Biotech1 week ago
Laminar Pharma Raises 5.9 Million in a New Round of Financing
-
Crypto23 hours ago
Bitcoin ETF Options Debut in the U.S.: Is a New All-Time High on the Horizon?